Michal Laufer Perl, Isreal

Director of the Cardiovascular Clinics and Head of the Heart Failure service at Tel Aviv Sourasky Medical Center, Israel

• Director of the Cardiovascular Clinics and Head of the Heart Failure service at Tel Aviv Sourasky Medical Center, Israel.
• Clinical Associate Professor, Gray Faculty of Medicine, Cardiology Department, Tel Aviv University, Israel.
• Master of Health Administration (MHA), Ben Gurion University, Israel.
• Observational Rotation in Cardio-oncology, Memorial Sloan Kettering Cancer Center, New York, USA (2016).
• Secretary of the Cardiomyopathy Section of the Israel Cardiology Association (2021-2025).
• Fellow of the ESC (FESC) and a fellow of the ESC HFA (FHFA).
• ESC “Heart Failure Specialists of Tomorrow” (HoT) (2018-2021).
• ESC HFA Committee Member on the Heart Failure Matters Committee and the Scientific Committee on Cardio-Oncology (2024-2026).
• Completed the ACC Global Leadership Institute.
• Deliver regulatory lectures and abstract presentations (47 abstracts) at national and international conferences; serve as the ACC 2026 Jeopardy leadership writer; and serve as a faculty participant in the ICI, ESC HFA and ESC conferences.
• Member of the Cardiology Board Examination Question-Writing Committee.
• Principal investigator in several multicenter cardiovascular trials like RELIEVE-HF, ALLAY, CORDIO, and PULNOVO.
• I secured approximately USD 500,000 in research funding.
• Published over 80 papers in highly prestigious journals in the field of cardiovascular.
• Reviewer (Lancet, JACC) and section editor of several leading international cardiovascular journals.

Lecture：

Session

Chair Role:

TBC